REG - HeiQ PLC - Director/PDMR Shareholding

HeiqAnnouncement

17/02/2022 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220217:nRSQ0456Ca&default-theme=true

RNS Number : 0456C  HeiQ PLC  17 February 2022

17 February 2022

 

HeiQ Plc

("HeiQ" or "the Company")

 

Director / PDMR Dealing

 

HeiQ Plc (LSE: HEIQ), a Swiss IP innovator and established global brand in
materials and textile innovation which operates in high-growth markets, has
been notified that on 16 February 2022, Carlo Centonze, Chief Executive
Officer of the Company, purchased 33,000 ordinary shares of 30 pence each in
the Company ("Ordinary Shares") at a price of 90 pence per share.

 

Following the purchase, Mr Centonze holds an interest in 13,887,146 Ordinary
Shares, including 5,186,237 Ordinary Shares held by Cortegrande AG, a company
wholly owned by Mr Centonze. The total interest held by Mr Centonze represents
approximately 10.63 per cent. of the Company's issued ordinary share capital.

 

This announcement, including the notification below, is made in accordance
with the requirements of the UK Market Abuse Regulation.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Carlo Centonze

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         HeiQ plc

 b)   LEI                                                          213800IGT65IMJDO4S03

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 30p each

      Identification code

                                                                   GB00BN2CJ299

 b)   Nature of the transaction                                    Purchase of Ordinary Shares

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   90.0p     33,000

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      16 February 2022

 f)   Place of the transaction                                     London Stock Exchange

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

16 February 2022

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

For further information, please contact:

 

 HeiQ Plc                                        +41 56 250 68 50

 Carlo Centonze (CEO)
 Cenkos Securities plc (Joint Broker)            +44 (0) 207 397 8900

 Stephen Keys / Callum Davidson
 SEC Newgate (Media Enquiries)                   +44 (0) 20 3757 6882

 Elisabeth Cowell / Robin Tozer / Megan Kovach   HeiQ@s (mailto:HeiQ@secnewgate.co.uk) ecnewgate (mailto:HeiQ@secnewgate.co.uk)
                                                 .co.uk (mailto:HeiQ@secnewgate.co.uk)

 

About HeiQ

HeiQ is focused on improving the lives of billions of people world-wide by
innovating the materials people use every day. HeiQ has strong IP which is at
the forefront of global technology in the $10 billion antimicrobial fabrics
market, $24 billion textile chemicals market, the $50 billion probiotics
market and the $150 billion man-made fibers market. It has also moved into the
medical device, healthcare and hygiene coatings markets, to help make
hospitals and healthcare environments more hygienic. HeiQ aims to deliver
growth for its shareholders through a combination of increased sales of its
core products and by entering additional lucrative markets through disruptive
innovations and M&A.

HeiQ has created some of the most effective, durable and high-performance
technologies in the market today, which cool, warm, dry, repel, purify, and
destroy viruses. Since 2005, HeiQ has developed over 200 technologies in
partnership with 300 major brands and it has a significant R&D pipeline
containing over 50 projects. The Company has won multiple awards and gained a
strong reputation for the ESG & sustainable downstream effect of its
innovations. HeiQ is the only company to have won the Swiss Technology award
twice. It has also won the Swiss Environmental award with an innovation that
saves energy and water consumption during the textile manufacturing process.

Led by an experienced leadership team, HeiQ researches new solutions for
partners, delivers scaled up manufacturing from its sites across the world and
helps partners market the product to end consumers - aiming for lab to
consumer in months.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFVSFFIDLIF